DuPont Unveils New Strategy to Expand its Seed Business

16-Dec-2008 - USA

DuPont business Pioneer Hi-Bred has unveiled a new business strategy to bring its seed genetics to more acres around the world through a network of partnerships and new brands. The strategy, called PROaccessSM, announced during the American Seed Trade Association’s annual conference, will increase Pioneer global seed market reach through co-brands, second brands and investments. In the United States alone, this strategy will allow Pioneer to have access to distribution systems that cover an additional 5 percent of corn acres.

“PROaccessSM adds to the momentum we have been building in the Pioneer business,” said Paul Schickler, Pioneer president and DuPont vice president and general manager.

“For more than 80 years, our goal has been to increase the productivity and profitability of Pioneer customers,” he continued. “PROaccessSM expands upon that mission by making available our unique, elite seed genetics to help our partners around the world expand their selection of high-performing products and increase their customers’ yields and income.”

Through the PROaccessSM model, Pioneer will develop customized business agreements with independent seed companies to address their specific needs.

“We know that the seed business is not one-size-fits-all. Each company has its own needs,” Schickler said. “That’s why we have built flexibility into this strategy by customizing the agreements to fit the individual needs of each company.”

Pioneer will manage the PROaccessSM business relationships separate from its Pioneer brand. The seed marketed and distributed by these companies will be unique and not available from Pioneer sales reps. PROaccessSM business agreements have been established in Brazil, Mexico, South Africa and the United States. Pioneer plans to continue expanding the number of partners and acres through the PROaccessSM strategy.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances